These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27859020)

  • 1. Systemic inflammation in acute intermittent porphyria: a case-control study.
    Storjord E; Dahl JA; Landsem A; Fure H; Ludviksen JK; Goldbeck-Wood S; Karlsen BO; Berg KS; Mollnes TE; W Nielsen E; Brekke OL
    Clin Exp Immunol; 2017 Mar; 187(3):466-479. PubMed ID: 27859020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: Results from a case-control study in northern Norway.
    Storjord E; Dahl JA; Landsem A; Ludviksen JK; Karlsen MB; Karlsen BO; Brekke OL
    Mol Genet Metab; 2019 Nov; 128(3):254-270. PubMed ID: 30583995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute intermittent porphyria in childhood: a population-based study.
    Hultdin J; Schmauch A; Wikberg A; Dahlquist G; Andersson C
    Acta Paediatr; 2003 May; 92(5):562-8. PubMed ID: 12839285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental and Periodontal Health in Acute Intermittent Porphyria.
    Storjord E; Airila-Månsson S; Karlsen K; Madsen M; Dahl JA; Landsem A; Fure H; Ludviksen JK; Fjøse JØ; Dickey AK; Karlsen BO; Waage Nielsen E; Mollnes TE; Brekke OL
    Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients.
    Delaby C; To-Figueras J; Deybach JC; Casamitjana R; Puy H; Herrero C
    J Intern Med; 2009 Sep; 266(3):277-85. PubMed ID: 19570056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
    Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma and salivary markers of oxidative and carbonyl stress in patients with acute intermittent porphyria].
    Mydlík M; Derzsiová K; Koborová I; Šebeková K
    Vnitr Lek; 2016; 62 Suppl 6():25-29. PubMed ID: 28124928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythms in acute intermittent porphyria--a pilot study.
    Larion S; Caballes FR; Hwang SI; Lee JG; Rossman WE; Parsons J; Steuerwald N; Li T; Maddukuri V; Groseclose G; Finkielstein CV; Bonkovsky HL
    Eur J Clin Invest; 2013 Jul; 43(7):727-39. PubMed ID: 23650938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl-3-acryloylglycine in urine of patients with acute intermittent porphyria.
    Marcos J; Ibañez M; Ventura R; Segura J; To-Figueras J; Pozo OJ
    J Mass Spectrom; 2015 Jul; 50(7):929-37. PubMed ID: 26349648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain magnetic resonance imaging white-matter lesions and cerebrospinal fluid findings in patients with acute intermittent porphyria.
    Bylesjö I; Brekke OL; Prytz J; Skjeflo T; Salvesen R
    Eur Neurol; 2004; 51(1):1-5. PubMed ID: 14631121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria.
    Gomez-Gomez A; Marcos J; Aguilera P; To-Figueras J; Pozo OJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():347-354. PubMed ID: 28666226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
    Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
    Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency.
    Collantes M; Serrano-Mendioroz I; Benito M; Molinet-Dronda F; Delgado M; Vinaixa M; Sampedro A; Enríquez de Salamanca R; Prieto E; Pozo MA; Peñuelas I; Corrales FJ; Barajas M; Fontanellas A
    Hum Mol Genet; 2016 Apr; 25(7):1318-27. PubMed ID: 26908609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients.
    Ferrer MD; Mestre-Alfaro A; Martínez-Tomé M; Carrera-Quintanar L; Capó X; Jiménez-Monreal AM; García-Diz L; Roche E; Murcia MA; Tur JA; Pons A
    PLoS One; 2016; 11(10):e0164857. PubMed ID: 27788171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary metabolic fingerprint of acute intermittent porphyria analyzed by (1)H NMR spectroscopy.
    Carichon M; Pallet N; Schmitt C; Lefebvre T; Gouya L; Talbi N; Deybach JC; Beaune P; Vasos P; Puy H; Bertho G
    Anal Chem; 2014 Feb; 86(4):2166-74. PubMed ID: 24437734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria.
    Casals G; Marcos J; Pozo ÓJ; Aguilera P; Herrero C; To-Figueras J
    Clin Biochem; 2013 Jun; 46(9):819-24. PubMed ID: 23499585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria.
    Serrano-Mendioroz I; Sampedro A; Mora MI; Mauleón I; Segura V; Enríquez de Salamanca R; Harper P; Sardh E; Corrales FJ; Fontanellas A
    J Proteomics; 2015 Sep; 127(Pt B):377-85. PubMed ID: 25979770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.
    Sardh E; Andersson DE; Henrichson A; Harper P
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):66-71. PubMed ID: 19268004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.